Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61B AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.0002729368METHOD FOR ASSESSING THE SEVERITY OF PNEUMONIA WITH COVID-19 USING AN ULTRASONIC EXAMINATION METHOD
RU 06.08.2020
Int.Class A61B 8/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
8Diagnosis using ultrasonic, sonic or infrasonic waves
08Detecting organic movements or changes, e.g. tumours, cysts, swellings
Appl.No 2020119236 Applicant Inventor Кириллова Маргарита Сергеевна (RU)
FIELD: medicine. SUBSTANCE: invention refers to medicine, namely to radiation diagnostics, and can be used for assessment of pneumonia severity in COVID-19 caused by SARS-CoV-2 virus by means of ultrasonic examination method. That is followed by ultrasonic scanning of the lungs in accordance with 20- or 16-zone protocol, which are presented in Figures 1 and 2, respectively, with location of the sensor along the intercostal space. Differentiating moderate or obvious interstitial changes. Moderate interstitial changes are determined by detecting a thickened uneven pleural line and more than two non-merging B lines, echogenicity of which is lower than echogenicity of pleural line, with maximum thickness of B-lines up to 3 mm at point of deviation from pleural line. Obvious interstitial changes are determined if two or more merging B lines are detected; non-merging B-lines, including single ones, echogenicity of which corresponds to pleural line echogenicity, having thickness of 3 mm and more at point of deviation from pleural line; micro-consolidations; cortical consolidations; extensive consolidations. Obvious interstitial changes are diagnosed both in the presence of one of the changes specified above, and at their various combinations. If observing the obvious interstitial changes in the study areas, the severity of pneumonia in COVID-19 caused by the SARS-CoV-2 virus is determined by formula: S=4n/N, where S is degree of severity, characterized by an area of pulmonary tissue involvement, n is number of zones with detected changes, N is total number of zones, on which there has been conducted an US examination. If the degree of severity is 0≤S<1, the lung involvement parenchyma area is stated to be 25 %. If value 1≤S<2 is obtained, the lung involvement parenchyma area is 25 to 50 %. If value 2≤S<3 is obtained, the area of the lung involvement parenchyma is 50–75 %. If the value S≥3 is obtained, the lung involvement parenchyma area is 75 % or more. EFFECT: method provides a simple and affordable assessment of the severity of pulmonary involvement in patients with pneumonia COVID-19 in pandemics by using an ultrasonic diagnostic technique. 1 cl, 11 dwg, 5 tbl, 5 ex
2.20100136513Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence
US 03.06.2010
Int.Class C12Q 1/70
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
70involving virus or bacteriophage
Appl.No 10570781 Applicant LOU JIANRONG Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the nucleocapsid gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARSCoV infection.

3.2020101210AUTOMATED SCREENING SYSTEM OF COVID-19 INFECTED PERSONS BY MEASUREMENT OF RESPIRATORY DATA THROUGH DEEP FACIAL RECOGNITION
AU 16.07.2020
Int.Class A61B 5/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
08Measuring devices for evaluating the respiratory organs
Appl.No 2020101210 Applicant ANGURAJ, DINESH KUMAR DR Inventor
More than 10 00 000 people were exposed to the novel coronavirus called COVID 19, which is transpired in Wuhan, China, in December 2019 and became a worldwide medical evacuation rapidly. Vigorous medication and enhanced allotment of hospital facilities in pandemic regions are substantial due to the increased rate of infectious disease. Precise and efficient medication helps to segregate the suspected cases to stabilize the spreading of infection. A severe hurdle is the lack of hospital and medical facilities in pandemic regions. COVID-19isan irregular breathing condition triggered by coronavirus infections, so numerous citizens typically wear masks to reduce the threats of being infected during the pandemic period. This invention presents FLIR E6 that uses RGB and thermal cameras for health screening to acquire the facial expressions in video frames. YOLO V3 is suggested for detecting the facial regions such as the forehead part and nostril areas. Based on the detection of the accurate region, the respiration data is extracted from the masked nostril region. Inevitably, the recurrent neural network model called Long Short Term Memory proposes for classifying as infected or healthy people based on respiratory data. This proposal exhibits that the contactless and smart screening test, which exploits the pre-scan process for virally infected people with high accuracy of detection and obtains relatively high performance. AUTOMATED SCREENING SYSTEM OF COVID-19 INFECTED PERSONS BY MEASUREMENT OF RESPIRATORY DATA THROUGH DEEP FACIAL RECOGNITION Diagram normalperson Fig 1: Data flow diagram
4.2020101336AN EFFICIENT MACHINE LEARNING TECHNIQUE TO TRACK THE COVID PATIENTS ALONG WITH SECONDARY CONTACTS
AU 30.07.2020
Int.Class G16H 10/60
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
10ICT specially adapted for the handling or processing of patient-related medical or healthcare data
60for patient-specific data, e.g. for electronic patient records
Appl.No 2020101336 Applicant D, SAISANTHIYA MRS Inventor
An efficient machine learning technique to track the COVID patients along with Primary and secondary contact lists is the proposed invention, which plays a vital role to avoid the spread of this highly contagious disease. Pandemics are bane to the world which will affect the economy and life style of the citizens of any country that is affected. Thus there is a need to automate the process of tracking down the contact list of the COVID patient and monitor the quarantined person 24*7 to check whether the person is violating the isolation rules or not. The invention aims at implementing machine learning and artificial intelligence techniques to statistically analyze the case studies and arriving at conclusions in fraction of time.
5.20080044816Assay for SARS coronavirus by amplification and detection of the replicase sequence
US 21.02.2008
Int.Class C12Q 1/68
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
Appl.No 10570704 Applicant Becton, Dickinson and Company Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

6.20090258340Assay for SARS coronavirus by amplification and detection of the replicase sequence
US 15.10.2009
Int.Class C12Q 1/68
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
Appl.No 12322520 Applicant Becton, Dickinson and Company Inventor Lou Jianrong

Primers and probes derived from SARS-CoV nucleic acid that facilitate detection and/or quantification of the replicase gene are disclosed. The disclosed sequences may be used in a variety of amplification and non-amplification formats for detection of SARS-CoV infection.

7.20050048465Method of collecting nasopharyngeal cells and secretions for diagnosis of viral upper respiratory infections and screening for nasopharyngeal cancer
US 03.03.2005
Int.Class C12Q 1/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
Appl.No 10923444 Applicant World Sense Technology Limited Inventor Tong Sun-Wing

The present invention provides a method of collecting nasopharyngeal specimens by introducing physiologic solution into the conjunctival sacs and collecting the irrigate that drains into the oroharynx. The invention further provides a kit to facilitate such a method. The present invention also provides a method of delivering a biological active to the eyes, nasal, nasopharyngeal, and oropharyngeal regions.

8.1249714Máquina expendedora de medios para evitar la propagación del coronavirus
ES 22.07.2020
Int.Class G01K 13/00
GPHYSICS
01MEASURING; TESTING
KMEASURING TEMPERATURE; MEASURING QUANTITY OF HEAT; THERMALLY-SENSITIVE ELEMENTS NOT OTHERWISE PROVIDED FOR
13Adaptations of thermometers for specific purposes
Appl.No 202030995 Applicant THOMAS MAQUINARIA Y AUTOMATISMO, S.L. Inventor CARPINTERO CANALEJO TOMAS
9.20050107324Modulation of CEACAM1 expression
US 19.05.2005
Int.Class C07H 21/02
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
21Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
02with ribosyl as saccharide radical
Appl.No 10889101 Applicant BENNETT C. F. Inventor Bennett C. Frank

Compounds, compositions and methods are provided for modulating the expression of CEACAM1. The compositions comprise oligonucleotides, targeted to nucleic acid encoding CEACAM1. Methods of using these compounds for modulation of CEACAM1 expression and for diagnosis and treatment of disease associated with expression of CEACAM1 are provided.

10.20040254472Methods and apparatus for a remote, noninvasive technique to detect core body temperature in a subject via thermal imaging
US 16.12.2004
Int.Class A61B 5/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
01Measuring temperature of body parts
Appl.No 10854574 Applicant MCQUILKIN GARY L Inventor McQuilkin Gary L.

An approach to noninvasively, remotely and accurately detect core body temperature in a warm-blooded subject, human or animal, via thermal imaging. Preferred features such as the use of in-frame temperature references, specific anatomical target regions and a physiological heat transfer model help the present invention to overcome pitfalls inherent with existing thermal imaging techniques applied to physiological screening applications. This invention provides the ability to noninvasively, remotely and rapidly screen for diseases or conditions that are characterized by changes in core body temperature. One human application of this invention is the remote screening for severe acute respiratory syndrome (SARS), since fever is a common, early symptom. Other diseases and conditions that affect the core body temperature of humans or animals may also be noninvasively and remotely detected with this invention.